KZA
Click for more information
0.00% 8.0¢ kazia therapeutics limited

Ann: In-licencing of Phase II-ready molecule - presentation-NRT.AX, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. mw03
    2,136 Posts.
    lightbulb Created with Sketch. 61
    clock Created with Sketch.
    31/10/16
    09:47
    Post #: 20241248
    Q If it is so good, why would Roche sell it?
    NRT Price at posting: 8.1¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Discover how gas production wells are progressing with successful drilling and promising early gas flows
right-arrow Created with Sketch.
EBR FDA commences substantive review of EBR’s PMA application
right-arrow Created with Sketch.
LU7 Strong preliminary feasibility for Bécancour Lithium Refinery
right-arrow Created with Sketch.
NEWS New gold-copper assays boost confidence in major porphyry target—discover the potential
right-arrow Created with Sketch.
NEWS Kathleen Valley’s first spodumene shipment departs—see how this company is advancing fast
right-arrow Created with Sketch.
NEWS New drilling at the Rogozna Project delivers a standout intercept, highlighting significant resource expansion potential
right-arrow Created with Sketch.
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.